{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:41:16Z","timestamp":1758033676722,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,16]]},"DOI":"10.7759\/cureus.92445","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T13:58:43Z","timestamp":1758031123000},"source":"Crossref","is-referenced-by-count":0,"title":["GM2 Gangliosidosis AB Variant: A Hidden Truth"],"prefix":"10.7759","author":[{"given":"In\u00eas","family":"Noites","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Sofia","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Laranjeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Taipa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Temudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f3nia","family":"Figueiroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1147836","article-title":"Multimodal optical imaging and genetic features of AB variant GM2 gangliosidosis: a case report","volume":"11","author":"Chen Q","year":"2023","unstructured":"Chen Q, Lu F. Multimodal optical imaging and genetic features of AB variant GM2 gangliosidosis: a case report. Front Pediatr. 2023, 11:1147836. 10.3389\/fped.2023.1147836","journal-title":"Front Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-016-0626-6","article-title":"GM2 gangliosidosis AB variant: novel mutation from India - a case report with a review","volume":"16","author":"Sheth J","year":"2016","unstructured":"Sheth J, Datar C, Mistri M, Bhavsar R, Sheth F, Shah K. GM2 gangliosidosis AB variant: novel mutation from India - a case report with a review. BMC Pediatr. 2016, 16:88. 10.1186\/s12887-016-0626-6","journal-title":"BMC Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2017_31","article-title":"GM2 activator deficiency caused by a homozygous exon 2 deletion in GM2A","volume":"38","author":"Hall PL","year":"2018","unstructured":"Hall PL, Laine R, Alexander JJ, Ankala A, Teot LA, Lidov HG, Anselm I. GM2 activator deficiency caused by a homozygous exon 2 deletion in GM2A. JIMD Rep. 2018, 38:61-5. 10.1007\/8904_2017_31","journal-title":"JIMD Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2020-0655","article-title":"Two patients from Turkey with a novel variant in the GM2A gene and review of the literature","volume":"34","author":"\u0130nci A","year":"2021","unstructured":"\u0130nci A, Cengiz Ergin FB, Bibero\u011flu G, Okur \u0130, Ezg\u00fc FS, T\u00fcmer L. Two patients from Turkey with a novel variant in the GM2A gene and review of the literature. J Pediatr Endocrinol Metab. 2021, 34:805-12. 10.1515\/jpem-2020-0655","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref5","article-title":"GM2 activator deficiency","author":"Xiao C","year":"2022","unstructured":"Xiao C, Toro C, Tifft C. GM2 activator deficiency. GeneReviews\u00ae [Internet]. Adam MP, Pagon RA, Wallace SE, et al. (ed): University of Washington, Seattle (WA); 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7916\/D8D21WQ0","article-title":"Mutation in GM2A leads to a progressive chorea-dementia syndrome","volume":"5","author":"Salih MA","year":"2015","unstructured":"Salih MA, Seidahmed MZ, El Khashab HY, et al.. Mutation in GM2A leads to a progressive chorea-dementia syndrome. Tremor Other Hyperkinet Mov (N Y). 2015, 5:306. 10.7916\/D8D21WQ0","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2017.01.017","article-title":"Atypical juvenile presentation of GM2 gangliosidosis AB in a patient compound-heterozygote for c.259G > T and c.164C > T mutations in the GM2A gene","volume":"11","author":"Martins C","year":"2017","unstructured":"Martins C, Brunel-Guitton C, Lortie A, Gauvin F, Morales CR, Mitchell GA, Pshezhetsky AV. Atypical juvenile presentation of GM2 gangliosidosis AB in a patient compound-heterozygote for c.259G > T and c.164C > T mutations in the GM2A gene. Mol Genet Metab Rep. 2017, 11:24-9. 10.1016\/j.ymgmr.2017.01.017","journal-title":"Mol Genet Metab Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2015_469","article-title":"GM2-gangliosidosis, AB variant: clinical, ophthalmological, MRI, and molecular findings","volume":"25","author":"Renaud D","year":"2016","unstructured":"Renaud D, Brodsky M. GM2-gangliosidosis, AB variant: clinical, ophthalmological, MRI, and molecular findings. JIMD Rep. 2016, 25:83-6. 10.1007\/8904_2015_469","journal-title":"JIMD Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136195","article-title":"The GM2 gangliosidoses: unlocking the mysteries of pathogenesis and treatment","volume":"764","author":"Toro C","year":"2021","unstructured":"Toro C, Zainab M, Tifft CJ. The GM2 gangliosidoses: unlocking the mysteries of pathogenesis and treatment. Neurosci Lett. 2021, 764:136195. 10.1016\/j.neulet.2021.136195","journal-title":"Neurosci Lett"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-59","article-title":"Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders","volume":"9","author":"Fern\u00e1ndez-Marmiesse A","year":"2014","unstructured":"Fern\u00e1ndez-Marmiesse A, Morey M, Pineda M, et al.. Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders. Orphanet J Rare Dis. 2014, 9:59. 10.1186\/1750-1172-9-59","journal-title":"Orphanet J Rare Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401509-gm2-gangliosidosis-ab-variant-a-hidden-truth","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T13:58:44Z","timestamp":1758031124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401509-gm2-gangliosidosis-ab-variant-a-hidden-truth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.92445","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}